Pitt Shield

Blood-Brain Barrier Closure Time After Controlled Ultrasound-Induced Opening Is Independent of Opening Volume.

Authors: O'Reilly MA, Hough O, Hynynen K

Microbubble-mediated focused ultrasound (US) opening of the blood-brain barrier (BBB) has shown promising results for the treatment of brain tumors and conditions such as Alzheimer disease. Practical clinical implementation of focused US treatments would aim to treat a substantial portion of the brain; thus, the safety of opening large volumes must be investigated. This study investigated whether the opened volume affects the time for the BBB to be restored after treatment. Sprague Dawley rats (n = 5) received bilateral focused US treatments. One hemisphere received a single sonication, and the contralateral hemisphere was targeted with 4 overlapping foci. Contrast-enhanced T1-weighted magnetic resonance imaging was used to assess the integrity of the BBB at 0, 6, and 24 hours after focused US. At time 0, there was no significant difference in the mean enhancement between the single- and multi-point sonications (mean ± SD, 29.7% ± 18.4% versus 29.7% ± 24.1%; P = .9975). The mean cross-sectional area of the BBB opening resulting from the multi-point sonication was approximately 3.5-fold larger than that of the single-point case (14.2 ± 4.7 versus 4.1 ± 3.3 mm<sup>2</sup> ; P < .0001). The opened volumes in 9 of 10 hemispheres were closed by 6 hours after focused US. The remaining treatment location had substantially reduced enhancement at 6 hours and was closed by 24 hours. Histologic analysis revealed small morphologic changes associated with this location. T2-weighted images at 6 and 24 hours showed no signs of edema. T2*-weighted images obtained at 6 hours also showed no signs hemorrhage in any animal. The time for the BBB to close after focused US was independent of the opening volume on the time scale investigated. No differences in treatment effects were observable by magnetic resonance imaging follow-up between larger- and smaller-volume sonications, suggesting that larger-volume BBB opening can be performed safely.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To determine if BBB closure time after FUS depends on oepning volume
Animal model / Human subject Rattus norvegicus (Sprague Dawley); strain: Sprague Dawley; age: not reported; sex: male
Disease model healthy
MRI or image guidance method 7T MRI system (BioSpec 70/30 USR; Bruker; Brillerica, MA)
Targeted brain region(s) Cerebral Hemisphere (Bilateral)
Target coordinates Not provided
Cargo name and characteristics Not specified in the provided paper text.
Route of administration not reported

Outcomes and Safety

Summary of Outcomes BBB opened in all sites and close within 6 hours in 9 of 10 hemispheres. The remaining closed by 24 hours. BBB closure time does not depend on opening volume
Duration of biological effect 6 to 24 hours
Safety-related matter No edema or hemmorhage observed. One small ischemic lesion observed at one site, no other tissue damage.

Brain Region

Ultrasound Parameters

Ultrasound instrument In-house-assembled lead zirconate titanate transducer (lead zirconate titanate from DeL. Piezo Specialties, LLC, West Palm Beach, FL)
FUS Frequency 551.5 kHz
FUS Intensity Not specified in provided text
FUS Pressure 0.29-0.30 Mpa
FUS Mode pulsed
Pulse duration 10 ms
Duration of a single FUS session 2 minutes
Focal Characteristics Diameter: 75 mm, focal length: 60 mm, focal number: 0.8, focal zone size: 3 mm lateral, 20 mm axial
Treatment frequency single session

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search